They say biotech taught pharma how to outsource. So what’s someone who has spent 31 years working in Big Pharma know about outsourcing from the vantage point of smaller organizations? A lot, it turns out. Francis Dumont spent quite a bit of his career at Pfizer dealing with outsourcing activities, and in the latter half of his career “due diligence and integration of biotech acquisitions.” Those acquisitions were often knee-deep in development and manufacturing outsourcing, and had selected their CDMOs – some wisely, some not so. Chief Editor Louis Garguilo sat down with Dumont just after he retired from Pfizer for an in-depth conversation on drug development and manufacturing outsourcing, resulting in the series of editorials that make up this ebook for Outsourced Pharma readers. Part strategist (although he doesn’t like that word much), philosopher, and nuts-and-bolts practicional of outsourcing and working with CDMOs, Dumont indeed has a lot to share that is helpful to any sized company.